Echo Therapeutics, Inc. announced earnings results for the third quarter ended September 30, 2015. For the quarter, the company reported net loss of $1.8 million or $0.16 per share, compared to $2.7 million or $0.21 per share, for the same period in 2014. The $900,000 decrease in net loss was a result of decreases in research and development (R&D) and selling, general and administrative (S,G&A) expenses.
Echo Therapeutics, Inc.
Equities
ECTE
US27876L2060
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+1.75% | 206B | |
+3.42% | 177B | |
+31.54% | 157B | |
+32.16% | 112B | |
+21.08% | 55.63B | |
-1.61% | 47.57B | |
-9.11% | 36.87B | |
-0.34% | 35.18B | |
+13.21% | 28.61B |